Gro O. Nygaard
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications
Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.
Journal: The New England journal of medicine
Published: July 01, 2026
Vaccination of immunosuppressed patients.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: April 21, 2026
Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study.
Journal: BMJ neurology open
Published: January 13, 2026
Revised diagnostic criteria for multiple sclerosis.
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: December 18, 2025
Correction: Revised diagnostic criteria for multiple sclerosis
Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
Published: December 18, 2025
Serum drug levels and JCV assay discrepancies after switching from originator to biosimilar natalizumab.
Journal: BMJ neurology open
Published: December 01, 2025
Real-world comparison of anti-CD20 therapies: efficacy, infections, and immune profiles in a German cohort.
Journal: Frontiers in immunology
Published: November 03, 2025
Thalamic nuclei volumes across psychiatric and neurological disorders: a multi-site magnetic resonance imaging study.
Journal: Translational psychiatry
Published: October 18, 2025
Pharmacokinetic-Pharmacodynamic Modelling of Repeated Ocrelizumab Dosing in Relapsing-Remitting Multiple Sclerosis.
Journal: Clinical pharmacokinetics
Published: October 07, 2025
Normative Modelling of Brain Volume in Multiple Sclerosis.
Journal: medRxiv : the preprint server for health sciences
Published: September 26, 2025
Accelerated grey matter degeneration in relapsing remitting multiple sclerosis.
Journal: medRxiv : the preprint server for health sciences
Published: July 09, 2025
Last Updated: 09/26/2026